Area of research
Infectious Diseases · Biochemistry
Research interest
Research interests include Blood transfusion and management, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Platelet Disorders and Treatments.
Convalescent plasma for people with COVID-19.
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with meta-analysis.
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
The 2024 international survey of platelet products and practice.
International Forum on Global Patient Blood Management: Summary.
International Forum on Global Patient Blood Management: Responses.
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines.
Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.
Mitigating the impact of blood shortages in England.
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Universal irradiation of platelets: Does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness.
Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Simvastatin in Critically Ill Patients with Covid-19.
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis.
Convalescent plasma for people with COVID-19: a living systematic review.
Convalescent plasma for people with COVID-19: a living systematic review.
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.